Informative note on the incorporation of the system of glucose monitoring through sensors flash in adult patients attached to Medical Entities for healthcare

Recommend this news

La Resolución de 26 de abril de 2019 de la Dirección General de Cartera de Servicios del Sistema Nacional de Salud y Farmacia hace público el acuerdo de la Comisión de prestaciones, aseguramiento y financiación de 5 de noviembre de 2018 y 29 de marzo de 2019, sobre el sistema de monitorización de glucosa mediante sensores tipo flash en adultos en la cartera común de servicios del Sistema Nacional de Salud.

This provision is part of the Annex 6.4.1. point (II portfolio of common services and primary care of point 1.4 of Annex III of the portfolio of common services of specialized care of the royal decree 1030/2006 of 15 September which establishes the portfolio of common services of the national health system and the procedure for their update.

In accordance with article depending of the royal decree 1026/2011, 15 July, which approves the regulations of the judicial mutualisme, and clause 2.2.2 of the current concert for healthcare beneficiaries of MUGEJU, signed with medical organizations and any new diagnosis or treatment that appears after the signing of the concert, will be mandatory means for medical organizations when the same applies to patients of the National health system.

For those mutualists who have opted to receive healthcare through medical entities, by a resolution of 5 June 2019, the management of MUGEJU has agreed as follows:

From 20 June 2019 medical entities will facilitate without any cost for the insurance, the "monitoring system through glucose sensors (flash type)" mutualists to adult (18 years or more) of MUGEJU, with type 1 diabetes mellitus engaged with insulin intensive therapy (multiple daily doses or insulin pump) and require perform at least six punctures per day for the automonitorización of glucose in the blood that are among the following groups:

  1. Pacientes con discapacidad visual o limitaciones funcionales graves que les imposibilite realizar punciones digitales o con trastornos funcionales cognitivos que les impida expresar la situación de hipoglucemia.
  2. Patients who suffer repetition hypos only for those that occur at least 4 times per week or when they have a 10% of the values of the readings of the glucómetro below 70 mg/dl after making an average of 6 controls capillary blood glucose per day.
  3. Pacientes embarazadas, así como las que planifiquen un embarazo natural o mediante reproducción humana asistida.
  4. Adolescents that exceed the 17 years and who come by using the glucose monitoring sensors (flash type).

Todo ello sin perjuicio de la actual implantación de la prestación en niños y adolescentes de 4 a 17 años que continuará en las mismas condiciones.

The attached to mutual health services Autonomous communities or INGESA can access this benefit by procedures and timetables to establish each Autonomous Community and INGESA.